M. Elazar

发表

Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction

T. Nishimura, Yajing Hu, Manhong Wu, 2013, The Journal of Pharmacology and Experimental Therapeutics.

Simplified RNA secondary structure mapping by automation of SHAPE data analysis

M. Elazar, J. Glenn, P. Pang, 2011, Nucleic acids research.

Discovery of a hepatitis C target and its pharmacological inhibitors by microfluidic affinity analysis

S. Quake, S. Maerkl, M. Elazar, 2008, Nature Biotechnology.

The interaction between the hepatitis C proteins NS4B and NS5A is involved in viral replication.

M. Elazar, J. Glenn, E. Sklan, 2015, Virology.

Identification of a Class of HCV Inhibitors Directed Against the Nonstructural Protein NS4B

N. Cho, M. Elazar, J. Glenn, 2010, Science Translational Medicine.

Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel

Curtis W. Frank, Wonjae Lee, Jeffrey S. Glenn, 2009, Biomedical Materials.

A novel quantitative microarray antibody capture assay identifies an extremely high hepatitis delta virus prevalence among hepatitis B virus–infected mongolians

M. Elazar, J. Glenn, V. Winn, 2016, Hepatology.

Hepatitis delta infection - Current and new treatment options.

M. Elazar, J. Glenn, C. Koh, 2017, Best practice & research. Clinical gastroenterology.

BjalphaIT: a novel scorpion alpha-toxin selective for insects--unique pharmacological tool.

M. Elazar, J. Tytgat, T. Arnon, 2005, Insect biochemistry and molecular biology.

Programmable antivirals targeting critical conserved viral RNA secondary structures from influenza A virus and SARS-CoV-2

S. Schaffert, P. Khatri, Rhiju Das, 2022, Nature Medicine.

HCV NS5A inhibitors: the devil is in the details.

M. Elazar, J. Glenn, 2014, Gastroenterology.

A Rab-GAP TBC Domain Protein Binds Hepatitis C Virus NS5A and Mediates Viral Replication

Jeffrey S. Glenn, Benjamin Aroeti, M. Winters, 2007, Journal of Virology.

Combination of Novel Therapies for HDV

M. Elazar, J. Glenn, 2022, Viruses.

Emerging concepts for the treatment of hepatitis delta.

M. Elazar, J. Glenn, 2017, Current opinion in virology.

The anti-hepatitis C agent nitazoxanide induces phosphorylation of eukaryotic initiation factor 2alpha via protein kinase activated by double-stranded RNA activation.

J. Puglisi, M. Elazar, Michael Liu, 2009, Gastroenterology.

Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide

M. Elazar, J. Glenn, B. Korba, 2008, Antimicrobial Agents and Chemotherapy.

Structural Map of a MicroRNA-122:Hepatitis C Virus Complex

M. Elazar, J. Glenn, P. Pang, 2011, Journal of Virology.

AaIT: from neurotoxin to insecticide.

M. Elazar, E. Zlotkin, E Zlotkin, 2000, Biochimie.

Targeting of an expressed neurotoxin by its recombinant baculovirus.

M. Elazar, E. Zlotkin, R. Levi, 2001, The Journal of experimental biology.

A Nucleotide Binding Motif in Hepatitis C Virus (HCV) NS4B Mediates HCV RNA Replication

M. Elazar, J. Glenn, T. Danieli, 2004, Journal of Virology.

The anti-genomic (negative) strand of Hepatitis C Virus is not targetable by shRNA

M. Kay, M. Elazar, J. Glenn, 2013, Nucleic acids research.

Amphipathic Helix-Dependent Localization of NS5A Mediates Hepatitis C Virus RNA Replication

C. Rice, M. Elazar, J. Glenn, 2003, Journal of Virology.

Isolation and Transcriptional Profiling of Purified Hepatic Cells Derived from Human Embryonic Stem Cells

M. Elazar, J. Glenn, W. H. Wong, 2008, Stem cells.

Phosphatidylinositol 4,5-bisphosphate is an HCV NS5A ligand and mediates replication of the viral genome.

N. Cho, M. Elazar, J. Glenn, 2015, Gastroenterology.

BjαIT: a novel scorpion α-toxin selective for insects—unique pharmacological tool

M. Elazar, J. Tytgat, T. Arnon, 2005 .

An N-Terminal Amphipathic Helix in Hepatitis C Virus (HCV) NS4B Mediates Membrane Association, Correct Localization of Replication Complex Proteins, and HCV RNA Replication

C. Rice, M. Elazar, J. Glenn, 2004, Journal of Virology.

Quantitative Evaluation of Viral Protein Binding to Phosphoinositide Receptors and Pharmacological Inhibition

Joshua A. Jackman, N. Cho, M. Elazar, 2017, Analytical chemistry.

The hepatitis C virus NS5A inhibitor (BMS-790052) alters the subcellular localization of the NS5A non-structural viral protein.

M. Elazar, J. Glenn, E. Sklan, 2011, Virology.

Long-term culture of human liver tissue with advanced hepatic functions.

Kate Shaw, Sheikh Tamir Rashid, M. Winters, 2017, JCI insight.

Identification and targeting of a pan-genotypic influenza A virus RNA structure that mediates packaging and disease

S. Schaffert, P. Khatri, Rhiju Das, 2021, bioRxiv.

Viral infection of human progenitor and liver-derived cells encapsulated in three-dimensional PEG-based hydrogel

M. Elazar, J. Glenn, E. Chiao, 2009, Biomedical materials.

Potential for Hepatitis C Virus Resistance to Nitazoxanide or Tizoxanide

M. Elazar, J. Glenn, B. Korba, 2008, Antimicrobial Agents and Chemotherapy.

Using Chimeric Mice with Humanized Livers to Predict Human Drug Metabolism and a Drug-Drug Interaction

T. Nishimura, Yajing Hu, Manhong Wu, 2013, The Journal of Pharmacology and Experimental Therapeutics.